AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 79 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $842 | +24.6% | 739 | 0.0% | 0.00% | – |
Q2 2023 | $676 | +63.3% | 739 | 0.0% | 0.00% | – |
Q1 2023 | $414 | – | 739 | 0.0% | 0.00% | – |
Q4 2022 | $0 | – | 739 | -23.3% | 0.00% | – |
Q3 2022 | $0 | – | 963 | 0.0% | 0.00% | – |
Q2 2022 | $0 | -100.0% | 963 | 0.0% | 0.00% | – |
Q1 2022 | $1,000 | -66.7% | 963 | 0.0% | 0.00% | – |
Q4 2021 | $3,000 | 0.0% | 963 | 0.0% | 0.00% | – |
Q3 2021 | $3,000 | -93.9% | 963 | -92.6% | 0.00% | – |
Q2 2021 | $49,000 | +8.9% | 13,056 | 0.0% | 0.00% | – |
Q1 2021 | $45,000 | +25.0% | 13,056 | +0.8% | 0.00% | – |
Q4 2020 | $36,000 | +800.0% | 12,956 | +679.5% | 0.00% | – |
Q3 2020 | $4,000 | -92.5% | 1,662 | -57.5% | 0.00% | – |
Q2 2020 | $53,000 | -41.1% | 3,909 | -67.1% | 0.00% | – |
Q1 2020 | $90,000 | – | 11,879 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alerce Investment Management, L.P. | 4,652,561 | $3,340,000 | 5.66% |
Orchard Capital Management, LLC | 1,762,731 | $1,265,000 | 0.36% |
Ikarian Capital, LLC | 1,200,000 | $860,000 | 0.11% |
Ikarian Capital, LLC | 800,000 | $575,000 | 0.08% |
XTX Topco Ltd | 102,392 | $74,000 | 0.03% |
Nantahala Capital Management | 965,800 | $693,000 | 0.03% |
Worth Venture Partners, LLC | 63,500 | $46,000 | 0.02% |
Ardent Capital Management, Inc. | 43,429 | $31,000 | 0.02% |
Virtus ETF Advisers LLC | 65,149 | $47,000 | 0.02% |
RICE HALL JAMES & ASSOCIATES, LLC | 513,292 | $368,000 | 0.02% |